Covaxin can Neutralize the India Variant, Says White House's Chief Medical Adviser
Covaxin vaccine, developed by Bharat Biotech, can neutralize the B1617 variant of COVID-19 virus. India recorded 360,960 new cases in the 24 hours to Wednesday morning according to Health Ministry data.
Covaxin vaccine, developed by Bharat Biotech, can neutralize the B1617 variant of COVID-19 virus. India recorded 360,960 new cases in the 24 hours to Wednesday morning according to Health Ministry data.
‘Bharat Biotech's Covaxin demonstrates protection against the new Covid-19 variants’
Tweet it Now
A modest reduction in neutralisation by a factor of 1.95 was observed against B1617 variant compared to vaccine variant. Despite this reduction, neutralising titre levels with B 1617 remain above levels expected to be protective.
No difference in neutralisation between B 117 first identified in the UK and vaccine strain was observed.
COVID-19 Vaccine Covaxin Effective Against Double Mutant Strain
The COVID-19 vaccine Covaxin effectively neutralizes the double mutant strain as well, said Indian Council of Medical Research (ICMR). Covaxin is effective against the UK variants as well as other strains of Covid-19.
The COVID-19 vaccine Covaxin effectively neutralizes the double mutant strain as well, said Indian Council of Medical Research (ICMR). Covaxin is effective against the UK variants as well as other strains of Covid-19.
Source-IANS
Vaccine Maker Bharat Biotech Scales Up Manufacturing Of Covaxin
Bharat Biotech has scaled up the manufacturing capacity to produce about 700 million doses of its COVID-19 vaccine Covaxin annually.
Bharat Biotech has scaled up the manufacturing capacity to produce about 700 million doses of its COVID-19 vaccine Covaxin annually.
Covid-19: Demand for Covaxin Grows Among Indians
India has administered over 2 crore vaccine doses so far and is giving away millions of doses of Covid-19 vaccines to other countries.
India has administered over 2 crore vaccine doses so far and is giving away millions of doses of Covid-19 vaccines to other countries.
